Biotech

All Articles

F 2G brings up $100M for 2nd effort to obtain brand new antifungal to market

.After F2G's 1st attempt to acquire a new class of antifungal to market was hindered due to the FDA,...

Moderna targets $1.1 B in R&ampD spending cuts, falls 5 plans amid success tensions

.Moderna has actually promised to reduce R&ampD costs through $1.1 billion through 2027. The selecti...

Sanofi's $80M bank on Key dystrophy medication ends in phase 3 fail

.Only four months after Sanofi bet $80 million in ahead of time cash money on Fulcrum Rehabs' losmap...

Oncternal equity sinks 60% among layoffs, trial terminations

.Cancer cells firm Oncternal Rehabs is folding all its clinical tests and also giving up workers, tu...

Roche is actually holding out chances that its injectable obesity prospect can inevitably show 25% weight loss in late-stage test

.Roche is holding out hopes that its own injectable being overweight possibility could eventually di...

Novo Nordisk hails 'exceptional' weight reduction lead for dual-acting dental medicine in early test

.Novo Nordisk has actually raised the cover on a period 1 trial of its dental amylin and also GLP-1 ...

AbbVie sues BeiGene over blood cancer cells medicine proprietary knowledge

.Simply a few quick weeks after gaining an FDA Fast Track tag for its investigational BTK degrader i...

Lilly provides one-two strike with second tranche of favorable data on regular blood insulin prospect

.Not long after a positive records reduce for Eli Lilly's efsitora alfa, the Indianapolis-based busi...

BridgeBio reduces gene therapy finances as scientific information disappoint

.BridgeBio Pharma is actually slashing its own genetics therapy finances and also pulling back comin...

GSK surrenders HSV vaccine wishes after phase 2 fall short, yielding ethnicity to Moderna, BioNTech

.GSK's effort to cultivate the first vaccination for genital herpes simplex virus (HSV) has ended in...